Clinical Trial Detail

NCT ID NCT02451865
Title Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Jonsson Comprehensive Cancer Center
Indications

non-small cell lung carcinoma

Therapies

Binimetinib + Docetaxel

Age Groups: adult

Additional content available in CKB BOOST